Immunomodulation in the critically ill

N. R. Webster, H. F. Galley (Corresponding Author)

Research output: Contribution to journalReview articlepeer-review

59 Citations (Scopus)


Immunotherapy in the critically ill is an appealing notion because of the apparent abnormal immune and inflammatory responses seen in so many patients. The administration of a medication that could alter immune responses and decrease mortality in patients with sepsis could represent a 'magic bullet'. Various approaches have been tried over the last 20 yr: steroids; anti-endotoxin or anti-cytokine antibodies; cytokine receptor antagonists; and other agents with immune-modulating side-effects. However, in some respects, research along these lines has been unsuccessful or disappointing at best. The current state of knowledge is summarized with particular reference to sepsis and the acute respiratory distress syndrome.

Original languageEnglish
Pages (from-to)70-81
Number of pages12
JournalBritish Journal of Anaesthesia
Issue number1
Publication statusPublished - 1 Jul 2009


  • Cytokines
  • Immune system
  • Intensive care
  • Respiratory distress system, adult
  • Systemic inflammatory response system


Dive into the research topics of 'Immunomodulation in the critically ill'. Together they form a unique fingerprint.

Cite this